<DOC>
	<DOCNO>NCT00822341</DOCNO>
	<brief_summary>TG-0054 CXCR4 antagonist stem cell mobilization effect prove animal model , fist human study investigator safety , tolerability PK/PD healthy subject .</brief_summary>
	<brief_title>Evaluating Safety , Tolerability , Pharmacokinetics Efficacy TG-0054 With Single IV Doses Escalation Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male female 18 45 year age inclusive Body mass index ( BMI ) range 19.0 30.0 kg/m² body weight ≥ 50 kg inclusive Good physical mental health status determine basis medical history general clinical examination Subjects must use consistent form acceptable oral birth control double barrier method ( intrauterine device ( IUD ) plus condom , spermicidal gel plus condom ) least 3 month prior study initiation Any medical condition ( selflimited illness ) require ongoing current medical attention History hematologic disorder include thromboembolic disease anemia Severe trauma , fracture , major surgery , biopsy parenchymal organ within past 3 month Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent Subjects currently smoke ( intake nicotine nicotinecontaining product ) give smoke less 6 month first administration study drug Subjects carriers Hepatitis B surface antigen ( HBsAg ) Hepatitis C antibody Human Immunodeficiency Virus ( HIV ) antibody positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>